By March 2, 2016 Uncategorized

List of FDA-approved treatments

Here is a list of FDA-approved treatments now available to treat HAE:

  • Cinryze ™ brand of C1-inhibitor has been FDA-approved for preventing HAE attacks. Cinryze ™is delivered intravenously and is approved for home infusion.
  • Berinert® brand of C1-inhibitor has been FDA-approved for treating acute abdominal, facial or laryngeal HAE attacks. Berinert® is delivered intravenously and is approved for on-demand treatment through self-administration.
  • Kalbitor® brand of plasma kallikrein inhibitor has been FDA-approved to treat acute HAE attacks in patients 12 years of age and older. Kalbitor® is delivered through subcutaneous injections.
  • Firazyr® brand of bradykinin receptor antagonist has been FDA-approved for treating acute HAE attacks in patients 18 years and older. Firazyr® is delivered by subcutaneous injection and is approved for self-administration
  • Ruconest® brand of C1-inhibitor [recombinant] has been FDA-approved for treating acute HAE attacks in adults and adolescents. RUCONEST® is delivered intravenously and is approved for self-administration.

About Web Author @ HAEA

Official content from US HAEA


24_7_140


For HAE Emergency:

If you are having an HAE medical emergency, please hang up and dial 911 immediately. For non- emergencies please contact your HAE treating doctor.


For non-emergency questions
– contact a Patient Advocate:

(866) 798-5598

Take action

– and make a difference


  Join our family – become a member of HAEA

  Call our Patient Advocates

  Join the HAEA Café

  Get a referral to an HAE Physician

  Become an Advocate for HAEA

  Have your family checked for HAE

  Join our group on Social Media

  Participate in an event

Participate in our Scientific Registry

  Shop for merchandise

  Volunteer

  Share your HAE story